FN1 and colorectal carcinoma: In addition, Fn in the gut may activate the JAK/STAT and MAPK/ERK pathways, inhibit anti-tumor immunity, and play an important role in CRC progression (Fang and Richardson, 2005; Yu et al., 2009).